Piramal Pharma Solutions holds opening ceremony for new API Plant at Aurora, Canada
Plant is part of the company's CAD $30 million capital investment in the site
Plant is part of the company's CAD $30 million capital investment in the site
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Krsnaa Diagnostics now has its footprints in Delhi.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Medicines, including insulin, to be available in 40 lower-income countries
Subscribe To Our Newsletter & Stay Updated